Komori
Nissha (7915) · InitiativeWithdrawal of USM's Southeast Asian vertical integration project

Promoting vertical integration in the supply chain

First written in FY2017. 4 of 8 entries say "Advanced", first in FY2020-Q3. Latest entry: FY2026-H1.

8entries
10years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017AdvancedFY2020-Q3 – FY20252017: 120172018: 020182019: 020192020: 120202021: 020212022: 020222023: 020232024: 120242025: 120252026: 42026
Same theme, other companies
Vertical Integration of the Medical Device Supply Chain and CDMO ExpansionA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026-H1Withdrawal of USM's Southeast Asian vertical integration projectAnnual report

    「This subsidiary acquisition was intended to promote the geographic expansion of the medical device CDMO business in Southeast Asia.」

    The acquisition of USM Healthcare was intended to achieve geographic expansion of the medical device CDMO business in Southeast Asia, but following inappropriate accounting practices before the acquisition, the company decided to transfer the shares and withdrew the expansion initiative related to this project.
  2. FY2025AdvancedAnnual report

    「USM Healthcare manufactures and sells stents for cardiology, devices for orthopedics, medical consumables and other products. It has vertically integrated its operations in-house, from product design and development through regulatory approval, manufacturing and sales, giving it a competitive advantage in pricing.」

    Regarding USM Healthcare, which was scheduled to be acquired after the filing, the company outlined plans to incorporate a medical device business handling design and development, regulatory approval, manufacturing and sales on an integrated basis, thereby expanding its medical device CDMO operations in Asia and advancing vertical integration.
  3. FY2024AdvancedAnnual report

    「Through this equity acquisition, we will acquire Cathtek's quality control systems, technologies and customer base for medical devices, while creating synergies with our accumulated injection-molding production capacity and mold-manufacturing technologies, with the aim of expanding the business.」

    The acquisition of Cathtek is advancing vertical integration of the medical device value chain by combining injection molding and mold-manufacturing technologies with quality control capabilities and a customer base for medical devices.
  4. FY2023AdvancedAnnual report

    「Through more than 30 years of experience in micromolding, Isometric has earned customers' trust as a solutions provider handling everything from design and development to the manufacture and assembly of molded components.」

    The company acquired a business handling medical device micromolding from design and development through manufacturing and assembly, advancing vertical integration across the value chain.
  5. FY2020-Q3AdvancedAnnual report

    「This acquisition will further advance the vertical integration of global contract manufacturing services in the Medical Technology business and deliver value to all customers. The Medical Technology business will strengthen its design and manufacturing capabilities in metal processing, expand production capacity in North America, and achieve global business expansion and growth.」

    The acquisition of Olympus's Norwalk plant gave concrete form to the vertical integration of medical device contract manufacturing services and the strengthening of metal-processing and North American production capabilities.
  6. FY2017First statedAnnual report

    「As an outline of the Fifth Medium-Term Management Plan, we have identified the promotion of vertical integration in the supply chain.」

    The company explicitly identified vertical integration of the supply chain as one of the portfolio restructuring measures under the Fifth Medium-Term Management Plan.
Moved together

"Expanding Industrial Materials and Global Markets through M&A" moved the same way as this thread, in the same document, in 5 of its 8 moves.

533333★123456
  1. ★This thread
  2. 1Expanding Industrial Materials and Global Markets through M&A5×
  3. 2Performance-Linked Share-Based Compensation3×
  4. 3Repayment of Borrowings and Working Capital Funding Through Unsecured Bonds3×
  5. 4Lean Production and Manufacturing Efficiency Improvements Adapted to Demand Fluctuations3×
  6. 5Securing the capabilities and diverse talent needed to support the business portfolio3×
  7. 6Business Impacts of Human Rights Violations3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nissha yet. It last moved in the M&A and Subsidiary Changes of 2026-09-04: "Dropped".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Promoting vertical integration in the supply chain | Nissha Co.,Ltd. (7915) | Komori